Bayer Cropscience Ag

Bayer Aktiengesellschaft

Bayer Animal Health Gmbh

Bayer Intellectual Property Gmbh

Elanco Animal Health Gmbh

Nihon Bayer Agrochem, K.k.

Fmc Corporation

Bayer Cropscience Gmbh

Bayal Animal Health Gmbh

Arysta Lifescience North America Corporation

Hans-Georg Schwarz

Kerstin Ilg

Mark Wilhelm Drewes

Dieter Feucht

Rolf Pontzen

Ulrich Goergens

Peter Dahmen

Ulrich Görgens

Andreas Turberg

Arnd Voerste

Werner Hallenbach

Otto Schallner

Daniela Portz

Roland Andree

Angela Becker

Stefan Lehr

Olga Malsam

Reiner Fischer

Bernd Alig

Nils Griebenow

Walter Hübsch

Thomas Bretschneider

Robert Velten

Ingo Wetcholowsky

Peter Jeschke

Eva-Maria Franken

Joachim Kluth

Toshio Goto

Akihiko Yanagi

Ulrike Wachendorff-Neumann

Klaus-Helmut Muller

Katsuhiko Shibuya

Pierre-Yves Coqueron

Karl-Heinz Linker

Wahed Ahmed Moradi

Peter Lösel

Ernst Rudolf F Gesing

Lothar Willms

Karl-Heinz Kuck

Philippe Desbordes

Jean-Pierre A Vors

Sergii Pazenok

Klaus-Helmut Müller

Joerg Nico Greul

Michael Maue

Dorothee Hoischen

Adeline Köhler

Johannes Köbberling

Iring Heisler

Axel Trautwein

Julia Johanna Hahn

Stefan Herrmann

Anne Decor

Ulrich Ebbinghaus-Kintscher

Thomas Simon Ilg

Johannes-Rudolf Jansen

Alexander Arlt

Eike Kevin Heilmann

Kristian Kather

Martin Adamczewski

Sebastian Horstmann

Yolanda Cancho Grande

Niels Lindner

Klaus-Helmut M&uuml;ller

Heinz-Juergen Wroblowsky

Achim Hense

Sascha Eilmus

Joachim Telser

Shinichi Narabu

Peter Loesel

Eiichi Shimojo

Simon Maechling

Silvia Cerezo-Galvez

Daiei Yamazaki

Martin Füβlein

Heiko Rieck

George Theodoridis

Achim Harder

Jörg Nico Greul

Jürgen Benting

Christian Arnold

Zeinab M Elshenawy

Udo Schneider

Hansjörg Dietrich

Ruediger Fischer

Stefan Schnatterer

Seishi Ito

Dominik Hager

Nina Kausch-Busies

Ruth Meissner

Alain Villier

Lars Rodefeld

Chieko Ueno

Darren Mansfield

Monika H Schmitt

Ralf Wischnat

Peter Helmut Schreier

Benjamin J Dugan

Lionel Carles

Stéphanie Gary

The present invention relates to novel compounds of general formula (I): withA being A1 or A: andin which T, X, Y, Ro, R, Rand Rare as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.

Anthelmintic compounds

The present invention covers new isoquinoline compounds of general formula (I): in which A, R, R, R, R, R, R, and Q are as defined herein, methods of preparing the compounds, intermediate compounds useful for preparing the compounds of formula (I), pharmaceutical compositions and combinations comprising the compounds of formula (I) and the use of the compounds of formula (D) for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.

Isoquinoline derivatives and their use for the treatment of parasitic infections

The present invention relates to novel heteroaryl-substituted aminoalkyl azole compounds of the general formula (I), in which the structural elements Y, Q, Q, R, R, Rand Rhave the meaning given in the description, to formulations and compositions comprising such compounds and for their use in the control of animal pests including arthropods and insects in plant protection and to their use for control of ectoparasites on animals.

Heteroaryl-substituted aminoalkyl azole compounds as pesticides

The present invention relates to novel heteroaryl-triazole and heteroaryl-tetrazole compounds of the general formula (I), in which the structural elements Y, Q, Q, R, R, R, R, Rand Rhave the meaning given in the description, to formulations and compositions comprising such compounds and for their use in the control of animal pests including arthropods and insects in plant protection and to their use for control of ectoparasites on animals.

Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides

The present invention relates to novel heteroaryl-triazole and heteroaryl-tetrazole compounds of the general formula (I), in which the structural elements Y, Q, Q, R, R, R, Rand Rhave the meaning given in the description, to formulations and compositions comprising such compounds and for their use in the control of animal pests including arthropods and insects in plant protection and to their use for control of ectoparasites on animals.

The present invention covers new quinoline compounds of general formula (I), in which A, R, R, R, R, R, R, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. 

Quinoline derivatives

The present application relates to the use of heterocyclic compounds for controlling animal pests including arthropods, insects and nematodes, to novel heterocyclic compounds, to processes for their preparation and to intermediates for preparing the heterocyclic compounds.

Heterocyclic compounds as pesticides

The present invention relates to novel heteroaryl-triazole and heteroaryl-tetrazole compounds of the general formula (I), in which the structural elements Y, Q, Q, R, R, R, Rand Rhave the meaning given in the description, to formulations and compositions comprising such compounds and for their use in the control of animal pests including arthropods and insects in plant protection and to their use for control of ectoparasites on animals. 

The present invention covers new quinoline compounds of general formula (I): in which A, R, R, R, R, R, R, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.

Anthelmintic quinoline-3-carboxamide derivatives

The present invention covers azaquinoline compounds of general formula (I), with A being (A1) or (A2), and in which T, R, R, R, R, R, Rand Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. 

Azaquinoline derivatives

The present invention covers quinoline compounds of general formula (I), in which A, R, R, R, R, R, R, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. 

Quinoline derivatives for treating infections with helminths

The present invention covers bicyclic pyrazole compounds of general formula (I): in which G, A, R, R, R, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. 

Bicyclic pyrazole derivatives

Growing community of inventors

Dorsten, Germany

Hans-Georg Schwarz